ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 124 filers reported holding ANIKA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,130,061 | -36.6% | 114,335 | -11.6% | 0.00% | -50.0% |
| Q2 2023 | $3,359,291 | -9.5% | 129,303 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,713,582 | +10.4% | 129,303 | +13.8% | 0.00% | 0.0% |
| Q4 2022 | $3,364,159 | +24.4% | 113,654 | +0.0% | 0.00% | +100.0% |
| Q3 2022 | $2,704,000 | +57.6% | 113,613 | +47.8% | 0.00% | 0.0% |
| Q2 2022 | $1,716,000 | -13.8% | 76,862 | -3.1% | 0.00% | 0.0% |
| Q1 2022 | $1,991,000 | -14.4% | 79,312 | +22.2% | 0.00% | 0.0% |
| Q4 2021 | $2,325,000 | +15.3% | 64,892 | +36.9% | 0.00% | 0.0% |
| Q3 2021 | $2,017,000 | -1.7% | 47,392 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,052,000 | +6.2% | 47,392 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,933,000 | +15.4% | 47,392 | +28.1% | 0.00% | 0.0% |
| Q4 2020 | $1,675,000 | +27.9% | 37,000 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $1,310,000 | -2.6% | 37,021 | +0.1% | 0.00% | 0.0% |
| Q2 2020 | $1,345,000 | – | 37,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |